Ozempic is part of a class of diabetes and obesity drugs that mimic the GLP-1 hormone the body naturally produces after eating, suppressing appetite and stimulating weight loss. But for some ...

The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...